SCHEMBL2884626

SCHEMBL2884626

O=C(Nc1ccc(C(=O)c2ccc(NC(=O)c3cccc(Cl)c3)c(C(=O)O)c2)cc1)c1cccc(Cl)c1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 5/20 0.69
AKR1C4 P17516 1/20 0.62
AKR1C3 P42330 1/20 0.62
AKR1C2 P52895 1/20 0.62
AKR1C1 Q04828 1/20 0.62
PRSS12 P56730 3/20 0.56
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
MAPT P10636 2/20 0.55
HTT P42858 1/20 0.55
KCNK3 O14649 1/20 0.54
KCNK9 Q9NPC2 1/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
KDM4E B2RXH2 1/20 0.53
GFER P55789 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6351306 0.86 SERPINE1 (0.82) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6349319 0.85 SERPINE1 (0.85) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL420616 0.82 SERPINE1 (1.00) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL16496264 0.82 SERPINE1 (0.76) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL13802448 0.81 MEN1 (0.78) MEN1KMT2AMAPTHTTKCNK3
SCHEMBL1307097 0.80 AKR1C2 (0.76) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6359691 0.80 SERPINE1 (0.71) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6353180 0.79 SERPINE1 (0.70) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6346671 0.79 SERPINE1 (0.70) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL1464661 0.79 MEN1 (0.79) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286215-A1 BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION 2010-11-11 US disclosed
CN-101835741-A Bis-aromatic compounds useful in the treatment of inflammation BIOLIPOX AB 2010-09-15 CN disclosed
EP-2185504-A2 BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION Biolipox AB (SE) 2010-05-19 EP disclosed
WO-2009030887-A2 BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2009-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286215-A1 BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION LTC4S, LTB4R2, LTB4R SERPINE1 590/4885AKR1C4 109/4885AKR1C3 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.